IRIDEX Corp
NASDAQ:IRIX

Watchlist Manager
IRIDEX Corp Logo
IRIDEX Corp
NASDAQ:IRIX
Watchlist
Price: 1.48 USD -3.27% Market Closed
Market Cap: $25.4m

Operating Margin

-6%
Current
Improving
by 9.2%
vs 3-y average of -15.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-6%
=
Operating Income
$-3.1m
/
Revenue
$50.6m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-6%
=
Operating Income
$-3.1m
/
Revenue
$50.6m

Peer Comparison

Country Company Market Cap Operating
Margin
US
IRIDEX Corp
NASDAQ:IRIX
25.2m USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.5B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
180.3B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
136.2B USD
Loading...
US
Stryker Corp
NYSE:SYK
135.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.4B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.3B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
46.8B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.4B USD
Loading...

Market Distribution

Lower than 71% of companies in the United States of America
Percentile
29th
Based on 14 112 companies
29th percentile
-6%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

IRIDEX Corp
Glance View

Market Cap
25.4m USD
Industry
Health Care

IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 119 full-time employees. The Company’s laser consoles products consist of Glaucoma, which includes Cyclo G6 laser and delivery devices used for the treatment of glaucoma; Medical Retina product, which includes IQ 532 Laser and IQ 577 Laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases, and its PASCAL Synthesis Photocoagulator for the treatment of retinal diseases; Surgical Retina, which includes OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL and OcuLight GLx laser photocoagulation systems. Its laser probes products consist of Glaucoma, which include MicroPulse P3 Probe, G-Probe and G-Probe Illuminate, and Surgical Retina probes, which include EndoProbe family of products used in vitrectomy procedures.

IRIX Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-6%
=
Operating Income
$-3.1m
/
Revenue
$50.6m
What is IRIDEX Corp's current Operating Margin?

The current Operating Margin for IRIDEX Corp is -6%, which is above its 3-year median of -15.2%.

How has Operating Margin changed over time?

Over the last 3 years, IRIDEX Corp’s Operating Margin has increased from -15% to -6%. During this period, it reached a low of -22.5% on Sep 28, 2024 and a high of -6% on Sep 27, 2025.

Back to Top